Literature DB >> 9702989

Endothelium and acute coronary syndromes.

J K Liao1.   

Abstract

The vascular endothelium is a dynamic endocrine organ that regulates contractile, secretory, and mitogenic activities in the vessel wall and hemostatic processes within the vascular lumen. Risk factors for atherosclerosis such as cigarette smoking, hypertension, and increased serum lipid concentrations impair endothelial function and lead to the development of atherosclerotic vessels, which cause acute coronary syndromes. Atherosclerotic vessels progress from scattered foam cells to complex lesions with a lipid core and fibrous cap. Factors that weaken and cause the rupture of the fibrous cap will expose circulating blood products to the procoagulant materials in the lipid core. Thrombosis and subsequent remodeling of the unstable plaque may be catastrophic or clinically silent depending on the degree of vascular occlusion and availability of collateral blood flow. Evidence is presented that supports the view that endothelial dysfunction is an early marker of atherosclerosis and an important contributor to the atherogenic process.

Entities:  

Mesh:

Year:  1998        PMID: 9702989

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  14 in total

Review 1.  Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment.

Authors:  Yasushi Matsuzawa; Amir Lerman
Journal:  Coron Artery Dis       Date:  2014-12       Impact factor: 1.439

Review 2.  [Regulation of endothelial NO production by Rho GTPase].

Authors:  U Laufs; M Endres; J K Liao
Journal:  Med Klin (Munich)       Date:  1999-04-15

3.  Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia.

Authors:  Chang-Jiang Ge; Shu-Zheng Lu; Yun-Dai Chen; Xiao-Fan Wu; Shen-Jiang Hu; Ying Ji
Journal:  Heart Vessels       Date:  2008-04-04       Impact factor: 2.037

4.  Reduction of Cardiovascular Risk through Angiotensin II Type 1 Receptor Antagonism : Focus on Olmesartan Medoxomil.

Authors:  Enrico Agabiti Rosei
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-01-22

5.  Deposition of free cholesterol in the blood vessels of patients with coronary artery disease: a possible novel mechanism for atherogenesis.

Authors:  Ricardo D Couto; Luís A O Dallan; Luiz A F Lisboa; Carlos H Mesquita; Carmen G C Vinagre; Raul C Maranhão
Journal:  Lipids       Date:  2007-04-19       Impact factor: 1.880

Review 6.  Beyond lipid-lowering: effects of statins on endothelial nitric oxide.

Authors:  Ulrich Laufs
Journal:  Eur J Clin Pharmacol       Date:  2003-02-18       Impact factor: 2.953

7.  Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunction.

Authors:  R Preston Mason; Ruslan Kubant; Gehan Heeba; Robert F Jacob; Charles A Day; Yehudi S Medlin; Philipp Funovics; Tadeusz Malinski
Journal:  Pharm Res       Date:  2007-12-18       Impact factor: 4.200

Review 8.  [Endothelial dysfunction in patients with acute coronary syndrome].

Authors:  S Fichtlscherer; A M Zeiher
Journal:  Herz       Date:  1999-11       Impact factor: 1.740

Review 9.  Mechanism of action of niacin on lipoprotein metabolism.

Authors:  V S Kamanna; M L Kashyap
Journal:  Curr Atheroscler Rep       Date:  2000-01       Impact factor: 5.967

10.  Miglitol improves postprandial endothelial dysfunction in patients with acute coronary syndrome and new-onset postprandial hyperglycemia.

Authors:  Daisuke Kitano; Masaaki Chiku; Yuxin Li; Yasuo Okumura; Daisuke Fukamachi; Tadateru Takayama; Takafumi Hiro; Satoshi Saito; Atsushi Hirayama
Journal:  Cardiovasc Diabetol       Date:  2013-06-19       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.